Founded in 1991, the Rocky Mountain Oncology Society (RMOS) is the largest oncology professional organization in the state. RMOS comprises a powerful community of oncologists, nurse practitioners, physician assistants, pharmacists, and other multidisciplinary care providers involved in the treatment of patients with cancer.
RMOS is one of 22 State Chapter Members managed by the Association of Community Cancer Centers (ACCC) and is a State Affiliate of the American Society of Clinical Oncology. Members receive valuable educational content and innovative resources designed to keep them ahead of the local and national challenges and trends directly impacting the high-quality care their patients deserve.
For more information, resources, and upcoming events visit rmos-colorado.com.
Wei Assesses Role of TROP2 and HER2 Status in Treatment With Sacituzumab for ER+ mBC
September 26th 2024During an in-person Community Case Forum in partnership with the Rocky Mountain Oncology Society, Mei Wei, MD, discussed data from the TROPiCS-02 trial of sacituzumab govitecan in patients with metastatic breast cancer.
Read More
Should Progression-Free Survival Be the Primary End Point for Registration of Oncology Drugs?
January 14th 2024If the title is correct, an article in the November 10 issue of the Journal of Clinical Oncology shows that many randomized trials in oncology are improperly designed and many drugs used in oncology have been approved based on the wrong end point.
Read More